President and CEO of Halozyme Therapeutics, Inc. (NASDAQ:HALO), Torley Helen, sells 50,000 shares worth $2,036,568

According to Halozyme Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 06:56 PM, company President and CEO, Torley Helen disclosed selling 50,000 shares at a cost of $40.73. At the time of this transaction (Nov 25), this trade was worth $2,036,568 in total. As of Nov 25, Torley Helen now owns 480,522 shares in total worth about $19,768,675.080000002.

For the last few recent trades made by Halozyme Therapeutics, Inc. (NASDAQ:HALO) President and CEO, Torley Helen, we have the following information:

Posted by George Daniels on Thursday November 26 2020, 1:51 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0